Frost & Sullivan Honors Stentor with Market Engineering Award for Technology Leadership.

Business Editors & Health/Medical & Technology Writers

SOUTH SAN FRANCISCO--(BW HealthWire)--Aug. 14, 2002

Stentor(R), a leader in medical image and information management, announced it has received Frost & Sullivan's prestigious Market Engineering Award for Technology Leadership.

The award is given annually to companies that have been selected as top of their class and have demonstrated leadership throughout all stages of the technology life cycle -- incubation, adaptation, adoption and maturity.

Frost & Sullivan analysts review a number of factors when determining each year's winner, including significance of the technology to the industry, customer service, adoption rate, time to market and product innovation. Stentor scored above others with similar Web-based PACS solutions, with a determining factor being the company's proprietary wavelet technology, which enables the distribution of full-fidelity digital images over existing networks and eliminates the need to upgrade infrastructure. Frost & Sullivan analysts were also impressed with Stentor's ability to provide Web-based image distribution not only to a facility's radiology department, but also its full healthcare network.

"While other vendors use a combination of client-server and Web-based architectures, Stentor has been at the forefront in developing and actually delivering a unitary Web-based solution robust enough to distribute and display images both within and beyond the traditional limits of the radiology department," said Frost & Sullivan industry analyst Antonio Garcia.

"This Technology Leadership award from acknowledged industry expert Frost & Sullivan further validates Stentor's position as the technology leader in enterprise-wide image distribution and management software," said Oran Muduroglu, president and chief executive officer of Stentor. "Stentor's enterprise-wide distribution system is currently operating in more than 120 hospitals across the country, and we will continue to raise the bar for new technology initiatives in the digital imaging industry."

Stentor's iSite(TM) Enterprise application is a no-risk, comprehensive solution that enables the immediate delivery of diagnostic-quality images to the desktop computer of every physician in a healthcare network. Stentor's no-risk business model allows hospitals to participate in a 30-day trial, which enables physicians immediate access to softcopy images and allows the IT department to experience how easily the system integrates into the hospital's infrastructure.

iSite(TM) Enterprise can simultaneously support hundreds of users without any noticeable loss of speed. It runs on standard desktop PCs and off-the-shelf servers, making the system ideal for use with a hospital's existing information technology infrastructure.

iSite(TM) 3.0 includes iSite Enterprise, iSite Radiology and iVault. iSite Radiology is a primary-diagnosis radiology-reading station and is the first diagnostic-reading station to present a complete overview of prior exams and patient history on a separate navigation console, dedicating the diagnostic monitor space for image display. iVault is an always-online long-term image storage solution designed for the multi-year storage of medical images. iVault uses a unique perpetual online medical imaging data storage model that stores all image data on an active image server and allows immediate data accessibility to all iSite users across the enterprise, eliminating the need for complex pre-fetch or auto-route schema.

About Stentor, Inc.

Stentor, Inc., a South San Francisco-based medical informatics company, is a world leader in medical image and information management. Through the company's patent-pending iSyntax(TM) technology, Stentor has created the iSite(TM) image and information management system -- the first viable option for the dynamic transfer of diagnostic-quality images and associated patient information throughout the hospital enterprise to all standard PCs. iSite's workflow engine is powered by Imaging Suite(TM), the medical industry's leading radiology workflow solution.

Stentor has raised more than $32 million in venture capital and is backed by leading companies with an impressive track record of innovation and success in the medical field, including Lancet Capital, Sanderling Biomedical Venture Capital, Gilo Ventures, UPMC HS, University of Pittsburgh, EMC Corporation and IDX Systems Corporation.

Stentor is an ISO 9001- and EN46001-certified facility and first received 510 k clearance to market its products and services from the FDA in October of 1999.

About Frost & Sullivan

Founded in 1961, Frost & Sullivan is recognized as a global leader in international strategic market consulting and training, with offices located worldwide. Frost & Sullivan presents Market Engineering Awards to companies that demonstrate excellence in their industry. The prestigious awards commend the diligence, commitment, and innovative business strategies required to advance in the increasingly competitive global marketplace. Frost & Sullivan rigorously analyzes specific criteria to determine Market Engineering Award recipients in a variety of regional and global market landscapes. For further information, visit www.frost.com.

(c)2002 Stentor Inc. All rights reserved. Stentor, the Stentor logo, Intelligent Informatics, iSite, iVault and iSyntax are trademarks of Stentor, Inc.

Imaging Suite is a trademark of IDX Investment Corporation.